NewAmsterdam Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NAMS and other ETFs, options, and stocks.

About NAMS

NewAmsterdam Pharma Co. NV is a clinical-stage biopharmaceutical company, which engages in the development of oral, non-statin medicine for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol. 

CEO
Michael H. Davidson
CEOMichael H. Davidson
Employees
68
Employees68
Headquarters
Naarden, Noord-Holland
HeadquartersNaarden, Noord-Holland
Founded
2022
Founded2022
Employees
68
Employees68

NAMS Key Statistics

Market cap
2.10B
Market cap2.10B
Price-Earnings ratio
-7.36
Price-Earnings ratio-7.36
Dividend yield
Dividend yield
Average volume
416.50K
Average volume416.50K
High today
$19.98
High today$19.98
Low today
$17.77
Low today$17.77
Open price
$18.40
Open price$18.40
Volume
864.43K
Volume864.43K
52 Week high
$27.29
52 Week high$27.29
52 Week low
$14.06
52 Week low$14.06

Analyst ratings

90%

of 10 ratings
Buy
90%
Hold
10%
Sell
0%

People also own

Based on the portfolios of people who own NAMS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.